Filing Details

Accession Number:
0001104659-17-017605
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-03-17 16:16:23
Reporting Period:
2017-03-15
Filing Date:
2017-03-17
Accepted Time:
2017-03-17 16:16:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1660719 Aralez Pharmaceuticals Inc. ARLZ () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1527710 Patrick James Tursi C/o Aralez Pharmaceuticals Inc.,
7100 West Credit Avenue, Suite 101
Mississauga A6 L5N 0E4
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares, Without Par Value Acquisiton 2017-03-15 4,750 $2.11 184,118 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct